Disappointing to see no quarter on quarter revenue growth, especially given last quarter was supposed to be an aberration with Chinese approvals delayed and Chinese New Year dampening sales.
I still think this is a great long term story, but for now 15c seems to be a fair price. Take away the R&D grant and cash burn was -$400k, with only $500k in the bank. If revenue doesn't pick up quickly another cap raising will be required in the near future.
Disappointing to see no quarter on quarter revenue growth,...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 66058 | 2 |
View Market Depth
| Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable
